Ausgabe 6/2021
Inhalt (16 Artikel)
Acknowledgement to Referees
An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer
Yen-Shen Lu, Winnie Yeo, Yoon-Sim Yap, Yeon Hee Park, Kenji Tamura, Huiping Li, Rebecca Cheng
Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis
Neil K. Mehta, Andraia R. Li, Shaun A. Nguyen, John M. Kaczmar, David M. Neskey, Terry A. Day
Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09
Akihito Tsuji, Masato Nakamura, Takanori Watanabe, Dai Manaka, Hiroshi Matsuoka, Masato Kataoka, Masahiro Takeuchi, Wataru Ichikawa, Masashi Fujii
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
Eliza A. Hawkes, Tycel Phillips, Lihua Elizabeth Budde, Armando Santoro, Nakhle S. Saba, Fernando Roncolato, Gareth P. Gregory, Gregor Verhoef, Fritz Offner, Cristina Quero, John Radford, Krzysztof Giannopoulos, Don Stevens, Aron Thall, Bo Huang, A. Douglas Laird, Robin Sandner, Stephen M. Ansell
Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration
Siwen Hu-Lieskovan, Fadi Braiteh, Juneko E. Grilley-Olson, Xiao Wang, Alison Forgie, Vinicius Bonato, Ira A. Jacobs, Jeffrey Chou, Melissa L. Johnson
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)
Massimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava, Massimo Guidoboni, Roberta Depenni, Alessandro Minisini, Francesca Consoli, Paolo Ascierto, Gaetana Rinaldi, Maria Banzi, Riccardo Marconcini, Rossana Gueli, Virginia Ferraresi, Marco Tucci, Giuseppe Tonini, Giovanni Lo Re, Michele Guida, Michele Del Vecchio, Ilaria Gioia Marcon, Paola Queirolo
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes
Christos Chouaid, Thomas Filleron, Didier Debieuvre, Maurice Pérol, Nicolas Girard, Eric Dansin, Hervé Lena, Radj Gervais, Sophie Cousin, Josiane Otto, Roland Schott, David Planchard, Anne Madroszyk, Courèche Kaderbhai, Pascale DUBRAY-Longeras, Sandrine Hiret, Eric Pichon, Christelle Clément-Duchêne, Gaëlle Chenuc, Gaëtane Simon, Lise Bosquet, Xavier QUantin
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy
Iris Y. Sheng, Shilpa Gupta, Chandana A. Reddy, Dana Angelini, Pauline Funchain, Tamara A. Sussman, Joseph Sleiman, Moshe C. Ornstein, Keith McCrae, Alok A. Khorana
Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools
Fausto Castagnetti, Gianni Binotto, Isabella Capodanno, Atto Billio, Elisabetta Calistri, Francesco Cavazzini, Monica Crugnola, Antonella Gozzini, Gabriele Gugliotta, Mauro Krampera, Alessandro Lucchesi, Anna Merli, Maria Cristina Miggiano, Claudia Minotto, Monica Poggiaspalla, Marzia Salvucci, Barbara Scappini, Mario Tiribelli, Elena Trabacchi, Gianantonio Rosti, Sara Galimberti, Massimiliano Bonifacio
Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer
Arnold Lee
Olaparib: A Review as First-Line Maintenance Therapy in Advanced Ovarian Cancer
Julia Paik
Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Rachel M. Layman
Correction to: Isatuximab: A Review of Its Use in Multiple Myeloma
James E. Frampton
Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Yvette N. Lamb